Position history for VANGUARD GROUP INC's holdings in Inhibrx Biosciences, Inc.
VANGUARD GROUP INC holds 623,084 shares of INBX (Inhibrx Biosciences, Inc.), worth $49.2M as of 2025-Q4. The position was increased (++4.7% shares). INBX represents 0.0% of VANGUARD GROUP INC's portfolio.
Current Value
$49.2M
Current Shares
623,084
Total Value Change
+$40.9M
Total Shares Change
+93,026
Other major holders of INBX: VIKING GLOBAL INVESTORS LP, MORGAN STANLEY, HighTower Advisors, LLC, BlackRock, Inc.
Increased |
| 623,084 |
+4.7% |
| $49.2M |
| 0.0% |
| $77.98 |
31 |
| 2025-Q3 | Decreased | 594,918 | -0.6% | $20M | 0.0% | $32.31 | 0 |
| 2025-Q2 | Increased | 598,448 | +1.7% | $8.5M | 0.0% | $14.43 | 28 |
| 2025-Q1 | Decreased | 588,323 | -3.2% | $8.2M | 0.0% | $14.12 | 0 |
| 2024-Q4 | Increased | 607,721 | +14.7% | $9.4M | 0.0% | $15.14 | 32 |
| 2024-Q3 | New | 530,058 | - | $8.3M | 0.0% | $15.52 | 38 |